European Biotech Acquisition Corp (EBAC) Key Ratios
$11.27
$-0.44
(-3.76%)
As on 02-Mar-2023 16:00EDT
Market cap
$184 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
559.5
P/B Ratio
1.3
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | -- | -- | -- |
| EBIT | -- | -- | -144.34 | -- | -- |
| Net Profit | -142.15 | -229.10 | -76.81 | -- | -- |
| EPS | -142.16 | -265.99 | -99.77 | -- | -- |
| Book Value | -- | -- | 2,430.54 | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Dec-22 | Dec-21 | Dec-20 |
| EBIT-Margin
| -- | -- | -- | -- | -- |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -- | -- | 0.60 | -- | -- |
| Return on Capital
| -- | -- | 0.60 | -- | -- |
| Return on Assets
| -- | -- | 0.27 | -- | -- |
| Debt to Equity (x)
| -- | -- | -- | -- | -- |
Profitability
ROCE
0.60
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
0.60
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
0.60
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
0.60
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
0.27
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
0.27
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-76.81
--
Year on year growth in profit after tax
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
-76.81
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EPS Growth
-0.70
--
Year on year growth in earnings per share
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
-0.70
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Current Ratio
0.45
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
0.45
|
1.81
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Asset Turnover
--
--
Sales / Average Total Assets
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
--
|
--
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Valuation
Price / Earnings
375.69
--
Current share price divided by earning per share in the last twelve months
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
375.69
|
107.46
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Price / Book Value
1.06
--
Current share price divided by book value per share in the latest financial year
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
1.06
|
-23.76
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EV/EBITDA
374.79
--
Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)
|
Company Name
|
Dec-22
|
Dec-21
|
Dec-20
|
Dec-19
|
Dec-18
|
|---|---|---|---|---|---|
|
European Biotech Acquisition Corp (EBAC)
|
374.79
|
106.88
|
--
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
